Gahil Pharmaceutical Private Limited

Gahil Pharmaceutical Private Limited - pharma in Dankuni, West Bengal, India. FY 2026 financials & compliance.
CIN U74999WB2017PTC221696 Incorporated 29 June 2017 ROC Kolkata HQ Dankuni, West Bengal, India
Active Private Limited Company pharma Startup India
Data last updated
Revenue · FY 2020
₹4.11 Lakh
▼ 65% YoY
Net loss · FY 2020
₹1.52 Lakh
Net margin -36.9%
EBITDA · FY 2020
-₹1.35 Lakh
EBITDA margin -32.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Gahil Pharmaceutical Private Limited

Data last updated:

Gahil Pharmaceutical Private Limited is a private limited company based in Dankuni, West Bengal, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 June 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74999WB2017PTC221696. Its GSTIN is 19AAGCG8996C1Z2 (West Bengal).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anuja Bharti and Vikash Kumar.

Its last annual general meeting (AGM) was held on 29 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Akashdeep Apartment Ground Floor South Subhash Pally T N Mukherjee Road, Dankuni, West Bengal, India – 712311.

As per the financials filed for FY 2020, the company reported a revenue of ₹4.11 Lakh, a decline of 65% compared to the previous year. For the same year it recorded a net loss of ₹1.52 Lakh (net margin -36.9%) and EBITDA of -₹1.35 Lakh (EBITDA margin -32.7%).

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74999WB2017PTC221696
Registration Number 221696
Incorporation Date 29 June 2017
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup

Recognitions & Rankings of Gahil Pharmaceutical

Startup India Government of India

Contact details

Gahil Pharmaceutical Private Limited's registered office is in Dankuni, West Bengal. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Akashdeep Apartment Ground Floor South Subhash Pally T N Mukherjee Road, Dankuni, West Bengal, India – 712311
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Gahil Pharmaceutical Private Limited, buy the company report.

Comprehensive company report
Gahil Pharmaceutical Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Gahil Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Gahil Pharmaceutical Private Limited, buy the company report.

Financials of Gahil Pharmaceutical Private Limited

FY 2020 filings available

Gahil Pharmaceutical Private Limited reported revenue of ₹4.11 Lakh (down 65% YoY) for FY 2020.

Revenue · FY 2020
₹4.11 Lakh ▼ 65%
Net loss · FY 2020
₹1.52 Lakh margin -36.9%
EBITDA · FY 2020
-₹1.35 Lakh margin -32.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 65%
EBITDA CAGR growth
1 year
▼ 195%

Revenue fell 65% in the latest year. EBITDA fell 195% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations₹4.11 Lakh
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹1.35 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.52 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin-32.7%
Net Profit Margin-36.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Gahil Pharmaceutical Private Limited, buy the company report.

Board of directors of Gahil Pharmaceutical Private Limited

Gahil Pharmaceutical has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anuja BhartiDirector29 Jun 20179 Years 4 MonthsCurrent
Vikash KumarDirector29 Jun 20179 Years 4 MonthsCurrent

Peer comparison

Gahil Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mantra Enagro Private Limited₹4.15 Lakh (FY 2025)593.0%Amreli, Gujarat, India
Mediswan Lifesciences Private Limited₹4.15 Lakh (FY 2025)-56.0%Vasai, Maharashtra, India
Gulf Quarry General Trading Private Limited₹4.13 Lakh (FY 2023)-3.0%Amritsar, Punjab, India
Medikrebs Formulations Private Limited₹4.12 Lakh (FY 2025)-41.0%Dhar, Madhya Pradesh, India
Cneu Health N Beauty Private Limited₹4.12 Lakh (FY 2024)Bangalore, Karnataka, India
Gahil Pharmaceutical Private Limitedthis company₹4.11 Lakh (FY 2020)-₹1.52 Lakh-36.9%-65.0%Dankuni, West Bengal, India
Sol Fragrances Private Limited₹4.11 Lakh (FY 2024)Gurugram, Haryana, India
Embark Organics Private Limited₹4.11 Lakh (FY 2024)-39.0%Shahabad Markanda, Haryana, India
Phulakios Global Private Limited₹4.09 Lakh (FY 2024)-93.0%Basti, Uttar Pradesh, India
Surmount Formulations Private Limited₹4.09 Lakh (FY 2025)72.0%Ankleshwar, Gujarat, India
Geocem Environmental Solutions Private Limited₹4.08 Lakh (FY 2025)-83.0%Hyderabad, Telangana, India

To see the full peer comparison of Gahil Pharmaceutical Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Gahil Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Gahil Pharmaceutical has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AAGCG8996C1Z2West BengalActive21 Aug 2017

To see the full GST registrations and return filing status of Gahil Pharmaceutical Private Limited, buy the company report.

Recent activity

Gahil Pharmaceutical Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Anuja Bharti was appointed as Director on 29 Jun 2017.

AGM
Gahil Pharmaceutical Private Limited last Annual general meeting of members was held on 29 Dec 2020 as per latest MCA records.
Filing
Gahil Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Kolkata Ii.
Appointed
Anuja Bharti was appointed as Director.
Appointed
Vikash Kumar was appointed as Director.
Incorporation
29 Jun 2017
Gahil Pharmaceutical Private Limited was registered on 29 Jun 2017 with Roc Kolkata Ii & aged 9 years 4 months as per MCA records.

Frequently asked questions

Gahil Pharmaceutical is an active private limited company based in Dankuni, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 June 2017 (9+ years old) and is registered under CIN U74999WB2017PTC221696.

Gahil Pharmaceutical has 2 current directors:

The latest financial statements of Gahil Pharmaceutical on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 29 December 2020. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Gahil Pharmaceutical is 19AAGCG8996C1Z2, registered in West Bengal.

The CIN (Corporate Identification Number) of Gahil Pharmaceutical is U74999WB2017PTC221696. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Gahil Pharmaceutical was incorporated on 29 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Gahil Pharmaceutical by revenue are Mantra Enagro Private Limited, Mediswan Lifesciences Private Limited, Gulf Quarry General Trading Private Limited, Medikrebs Formulations Private Limited, Cneu Health N Beauty Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Anuja Bharti was appointed as Director on 29 Jun 2017. Vikash Kumar was appointed as Director on 29 Jun 2017.

Yes, Gahil Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

The registered office of Gahil Pharmaceutical is at Akashdeep Apartment Ground Floor South Subhash Pally T N Mukherjee Road, Dankuni, West Bengal, India – 712311.

Gahil Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.